Inactive Instrument

News Bioadaptives Inc OTC Bulletin Board

Equities

US09072U1079

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10	CI
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System	Feb. 22	AQ
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	Feb. 22	CI
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management	Feb. 01	AQ
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System	Jan. 17	AQ
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System	Jan. 17	CI
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products	Jan. 04	AQ
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management	Dec. 21	AQ
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based “Fit Your Outfit” app	Dec. 14	AQ
BioAdaptives Inc. Announces the Development of PROTEINnMORETM	Dec. 14	CI
BioAdaptives Announces Special Holiday Wellness Offers and Gift	Dec. 07	AQ
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	Nov. 16	AQ
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	Nov. 16	CI
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR™ System as US Enters Flu Season	Nov. 09	AQ
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season	Nov. 09	CI
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement	Nov. 02	AQ
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ™ Natural Supplement	23-10-26	AQ
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition	23-10-12	AQ
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement	23-10-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bioadaptives Inc OTC Bulletin Board

Equities

US09072U1079

Summary

Filters